APO Research

APO RESEARCH · REPORT

Crizotinib Drugs

Selected research

Industry Growth & Trends

Global Crizotinib Drugs Industry Growth and Trends Forecast to 2032

Market perspective

The global Crizotinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Crizotinib Drugs include Wanbang Biopharmaceuticals, Pfizer, Genvio Pharma, Everest Pharmaceuticals, Drug International, Beacom and Azista, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Crizotinib Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Crizotinib Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Crizotinib Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Crizotinib Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Crizotinib Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Crizotinib Drugs Market by Company

Wanbang Biopharmaceuticals

Pfizer

Genvio Pharma

Everest Pharmaceuticals

Drug International

Beacom

Azista

Crizotinib Drugs Segment by Type

Capsules

Oral Pellets

Crizotinib Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Crizotinib Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crizotinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crizotinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crizotinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Crizotinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Crizotinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Oral Pellets Table 3. Global Crizotinib Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Crizotinib Drugs Sales by Type (2021-2026) & (k units) Table 5. Global Crizotinib Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Crizotinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Crizotinib Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Crizotinib Drugs Price by Type (2021-2026) & (US$/unit) Table 9. Global Crizotinib Drugs Sales by Type (2027-2032) & (k units) Table 10. Global Crizotinib Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Crizotinib Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Crizotinib Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Crizotinib Drugs Price by Type (2027-2032) & (US$/unit) Table 14. North America Crizotinib Drugs Sales by Type (2021-2026) & (k units) Table 15. North America Crizotinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Crizotinib Drugs Sales by Type (2021-2026) & (k units) Table 17. Europe Crizotinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Crizotinib Drugs Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Crizotinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Crizotinib Drugs Sales by Type (2021-2026) & (k units) Table 21. Latin America Crizotinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Crizotinib Drugs Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Crizotinib Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Crizotinib Drugs Industry Trends Table 25. Crizotinib Drugs Industry Drivers Table 26. Crizotinib Drugs Industry Opportunities and Challenges Table 27. Crizotinib Drugs Industry Restraints Table 28. Global Crizotinib Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Crizotinib Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Crizotinib Drugs Sales by Company (2021-2026) & (k units) Table 31. Global Crizotinib Drugs Sales Share by Company (2021-2026) Table 32. Global Crizotinib Drugs Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Crizotinib Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Crizotinib Drugs Major Company Production Sites and Headquarters Table 35. Global Crizotinib Drugs Company, Product Type & Application Table 36. Global Crizotinib Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Crizotinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Crizotinib Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Crizotinib Drugs Sales by Region (2021-2026) & (k units) Table 41. Global Crizotinib Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Crizotinib Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Crizotinib Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Crizotinib Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Crizotinib Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Crizotinib Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Crizotinib Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Crizotinib Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Crizotinib Drugs Sales by Application (2021-2026) & (k units) Table 52. Global Crizotinib Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Crizotinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Crizotinib Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Crizotinib Drugs Price by Application (2021-2026) & (US$/unit) Table 56. Global Crizotinib Drugs Sales by Application (2027-2032) & (k units) Table 57. Global Crizotinib Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Crizotinib Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Crizotinib Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Crizotinib Drugs Price by Application (2027-2032) & (US$/unit) Table 61. North America Crizotinib Drugs Sales by Application (2021-2026) & (k units) Table 62. North America Crizotinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Crizotinib Drugs Sales by Application (2021-2026) & (k units) Table 64. Europe Crizotinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Crizotinib Drugs Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Crizotinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Crizotinib Drugs Sales by Application (2021-2026) & (k units) Table 68. Latin America Crizotinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Crizotinib Drugs Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Crizotinib Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Wanbang Biopharmaceuticals Company Information Table 72. Wanbang Biopharmaceuticals Business Overview Table 73. Wanbang Biopharmaceuticals Crizotinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Wanbang Biopharmaceuticals Crizotinib Drugs Product Portfolio Table 75. Wanbang Biopharmaceuticals Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Crizotinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Pfizer Crizotinib Drugs Product Portfolio Table 80. Pfizer Recent Development Table 81. Genvio Pharma Company Information Table 82. Genvio Pharma Business Overview Table 83. Genvio Pharma Crizotinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Genvio Pharma Crizotinib Drugs Product Portfolio Table 85. Genvio Pharma Recent Development Table 86. Everest Pharmaceuticals Company Information Table 87. Everest Pharmaceuticals Business Overview Table 88. Everest Pharmaceuticals Crizotinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Everest Pharmaceuticals Crizotinib Drugs Product Portfolio Table 90. Everest Pharmaceuticals Recent Development Table 91. Drug International Company Information Table 92. Drug International Business Overview Table 93. Drug International Crizotinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Drug International Crizotinib Drugs Product Portfolio Table 95. Drug International Recent Development Table 96. Beacom Company Information Table 97. Beacom Business Overview Table 98. Beacom Crizotinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Beacom Crizotinib Drugs Product Portfolio Table 100. Beacom Recent Development Table 101. Azista Company Information Table 102. Azista Business Overview Table 103. Azista Crizotinib Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Azista Crizotinib Drugs Product Portfolio Table 105. Azista Recent Development Table 106. North America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Crizotinib Drugs Sales by Country (2021-2026) & (k units) Table 108. North America Crizotinib Drugs Sales Market Share by Country (2021-2026) Table 109. North America Crizotinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Crizotinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 111. North America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Crizotinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Crizotinib Drugs Market Share by Country (2021-2026) Table 114. North America Crizotinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Crizotinib Drugs Market Share Forecast by Country (2027-2032) Table 116. Europe Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Crizotinib Drugs Sales by Country (2021-2026) & (k units) Table 118. Europe Crizotinib Drugs Sales Market Share by Country (2021-2026) Table 119. Europe Crizotinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Crizotinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Crizotinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Crizotinib Drugs Market Share by Country (2021-2026) Table 124. Europe Crizotinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Crizotinib Drugs Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Crizotinib Drugs Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Crizotinib Drugs Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Crizotinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Crizotinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Crizotinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Crizotinib Drugs Market Share by Country (2021-2026) Table 134. Asia-Pacific Crizotinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Crizotinib Drugs Market Share Forecast by Country (2027-2032) Table 136. Latin America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Crizotinib Drugs Sales by Country (2021-2026) & (k units) Table 138. Latin America Crizotinib Drugs Sales Market Share by Country (2021-2026) Table 139. Latin America Crizotinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Crizotinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Crizotinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Crizotinib Drugs Market Share by Country (2021-2026) Table 144. Latin America Crizotinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Crizotinib Drugs Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Crizotinib Drugs Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Crizotinib Drugs Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Crizotinib Drugs Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Crizotinib Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Crizotinib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Crizotinib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Crizotinib Drugs Market Share by Country (2021-2026) Table 154. Middle East and Africa Crizotinib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Crizotinib Drugs Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Crizotinib Drugs Distributors List Table 159. Crizotinib Drugs Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Crizotinib Drugs Image Figure 2. Global Crizotinib Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crizotinib Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Crizotinib Drugs Sales (2021-2032) & (k units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Pellets Image Figure 8. Global Oral Pellets Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Crizotinib Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Crizotinib Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Crizotinib Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Crizotinib Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Crizotinib Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Crizotinib Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Crizotinib Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Crizotinib Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Crizotinib Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Crizotinib Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Crizotinib Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Crizotinib Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Crizotinib Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (k units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Crizotinib Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Crizotinib Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Crizotinib Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Crizotinib Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Crizotinib Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Crizotinib Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Crizotinib Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Crizotinib Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Crizotinib Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Crizotinib Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Crizotinib Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Crizotinib Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Crizotinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Crizotinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Crizotinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Crizotinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Crizotinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Crizotinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Crizotinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Crizotinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Crizotinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Crizotinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Crizotinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Crizotinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Crizotinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Crizotinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Crizotinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Crizotinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Crizotinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Crizotinib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Crizotinib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Crizotinib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Crizotinib Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Crizotinib Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Oral Pellets
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Wanbang Biopharmaceuticals
  • Pfizer
  • Genvio Pharma
  • Everest Pharmaceuticals
  • Drug International
  • Beacom
  • Azista

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crizotinib Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Crizotinib Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Crizotinib Drugs Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Oral Pellets
  8. 1.4 Global Crizotinib Drugs Market Size by Type
  9. 1.4.1 Global Crizotinib Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Crizotinib Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Crizotinib Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Crizotinib Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Crizotinib Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Crizotinib Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Crizotinib Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Crizotinib Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Crizotinib Drugs Industry Trends
  2. 2.2 Crizotinib Drugs Industry Drivers
  3. 2.3 Crizotinib Drugs Industry Opportunities and Challenges
  4. 2.4 Crizotinib Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Crizotinib Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Crizotinib Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Crizotinib Drugs Price (2021-2026)
  4. 3.4 Global Crizotinib Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Crizotinib Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Crizotinib Drugs Company, Product Type & Application
  7. 3.7 Global Crizotinib Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Crizotinib Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Crizotinib Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Crizotinib Drugs Tier 1, Tier 2, and Tier 3
4 Crizotinib Drugs Regional Status and Outlook
  1. 4.1 Global Crizotinib Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Crizotinib Drugs Historic Market Size by Region
  3. 4.2.1 Global Crizotinib Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Crizotinib Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Crizotinib Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Crizotinib Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Crizotinib Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Crizotinib Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Crizotinib Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Crizotinib Drugs by Application
  1. 5.1 Crizotinib Drugs Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Crizotinib Drugs Market Size by Application
  6. 5.2.1 Global Crizotinib Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Crizotinib Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Crizotinib Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Crizotinib Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Crizotinib Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Crizotinib Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Crizotinib Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Crizotinib Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wanbang Biopharmaceuticals
  2. 6.1.1 Wanbang Biopharmaceuticals Company Information
  3. 6.1.2 Wanbang Biopharmaceuticals Business Overview
  4. 6.1.3 Wanbang Biopharmaceuticals Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wanbang Biopharmaceuticals Crizotinib Drugs Product Portfolio
  6. 6.1.5 Wanbang Biopharmaceuticals Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Crizotinib Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Genvio Pharma
  14. 6.3.1 Genvio Pharma Company Information
  15. 6.3.2 Genvio Pharma Business Overview
  16. 6.3.3 Genvio Pharma Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Genvio Pharma Crizotinib Drugs Product Portfolio
  18. 6.3.5 Genvio Pharma Recent Developments
  19. 6.4 Everest Pharmaceuticals
  20. 6.4.1 Everest Pharmaceuticals Company Information
  21. 6.4.2 Everest Pharmaceuticals Business Overview
  22. 6.4.3 Everest Pharmaceuticals Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Everest Pharmaceuticals Crizotinib Drugs Product Portfolio
  24. 6.4.5 Everest Pharmaceuticals Recent Developments
  25. 6.5 Drug International
  26. 6.5.1 Drug International Company Information
  27. 6.5.2 Drug International Business Overview
  28. 6.5.3 Drug International Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Drug International Crizotinib Drugs Product Portfolio
  30. 6.5.5 Drug International Recent Developments
  31. 6.6 Beacom
  32. 6.6.1 Beacom Company Information
  33. 6.6.2 Beacom Business Overview
  34. 6.6.3 Beacom Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beacom Crizotinib Drugs Product Portfolio
  36. 6.6.5 Beacom Recent Developments
  37. 6.7 Azista
  38. 6.7.1 Azista Company Information
  39. 6.7.2 Azista Business Overview
  40. 6.7.3 Azista Crizotinib Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Azista Crizotinib Drugs Product Portfolio
  42. 6.7.5 Azista Recent Developments
7 North America by Country
  1. 7.1 North America Crizotinib Drugs Sales by Country
  2. 7.1.1 North America Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Crizotinib Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Crizotinib Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Crizotinib Drugs Market Size by Country
  6. 7.2.1 North America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Crizotinib Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Crizotinib Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Crizotinib Drugs Sales by Country
  2. 8.1.1 Europe Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Crizotinib Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Crizotinib Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Crizotinib Drugs Market Size by Country
  6. 8.2.1 Europe Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Crizotinib Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Crizotinib Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Crizotinib Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Crizotinib Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Crizotinib Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Crizotinib Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Crizotinib Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Crizotinib Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Crizotinib Drugs Sales by Country
  2. 10.1.1 South America Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Crizotinib Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Crizotinib Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Crizotinib Drugs Market Size by Country
  6. 10.2.1 South America Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Crizotinib Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Crizotinib Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Crizotinib Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Crizotinib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Crizotinib Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Crizotinib Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Crizotinib Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Crizotinib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Crizotinib Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Crizotinib Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Crizotinib Drugs Value Chain Analysis
  2. 12.1.1 Crizotinib Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Crizotinib Drugs Production Mode & Process
  7. 12.2 Crizotinib Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Crizotinib Drugs Distributors
  10. 12.2.3 Crizotinib Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research